DIABETIC END STAGE RENAL DISEASE

DIABETIC END STAGE RENAL DISEASE was reported 52 times

DIABETIC END STAGE RENAL DISEASE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Calcitonin [EPC] 1 0.0003
1 Insulin [EPC] 4 0.0001
2 Non-narcotic Antitussive [EPC] 1 0.0001
3 Provitamin D2 Compound [EPC] 1 0.0000
4 Proton Pump Inhibitor [EPC] 19 0.0000
5 Cardiac Glycoside [EPC] 2 0.0000
6 Muscle Relaxant [EPC] 1 0.0000
7 Macrolide Antimicrobial [EPC] 1 0.0000
8 Central alpha-2 Adrenergic Agonist [EPC] 1 0.0000
9 Erythropoiesis-stimulating Agent [EPC] 1 0.0000
10 Antidote [EPC] 1 0.0000
11 Angiotensin Converting Enzyme Inhibitor [EPC] 2 0.0000
12 alpha-Adrenergic Blocker [EPC] 2 0.0000
13 HER2/neu Receptor Antagonist [EPC] 1 0.0000
14 Calcium [EPC] 2 0.0000
15 Histamine-1 Receptor Antagonist [EPC] 1 0.0000
16 Xanthine Oxidase Inhibitor [EPC] 2 0.0000
17 Integrin Receptor Antagonist [EPC] 1 0.0000
18 Nitrate Vasodilator [EPC] 1 0.0000
19 Vascular Endothelial Growth Factor Inhibitor [EPC] 2 0.0000
20 beta-Adrenergic Blocker [EPC] 3 0.0000
21 5-alpha Reductase Inhibitor [EPC] 1 0.0000
22 Insulin Analog [EPC] 4 0.0000
23 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
24 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
25 Sulfonylurea [EPC] 1 0.0000
26 HMG-CoA Reductase Inhibitor [EPC] 3 0.0000
27 Phosphodiesterase 5 Inhibitor [EPC] 1 0.0000
28 Platelet Aggregation Inhibitor [EPC] 4 0.0000
29 Atypical Antipsychotic [EPC] 3 0.0000
30 Loop Diuretic [EPC] 3 0.0000
31 Aldosterone Antagonist [EPC] 1 0.0000
32 Azole Antifungal [EPC] 1 0.0000
33 Thiazide Diuretic [EPC] 1 0.0000
34 Nonsteroidal Anti-inflammatory Drug [EPC] 6 0.0000
35 GLP-1 Receptor Agonist [EPC] 2 0.0000
36 Factor Xa Inhibitor [EPC] 1 0.0000
37 Osmotic Laxative [EPC] 1 0.0000
38 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
39 Vitamin C [EPC] 1 0.0000
40 Benzodiazepine [EPC] 1 0.0000
41 Tumor Necrosis Factor Blocker [EPC] 1 0.0000
42 Corticosteroid [EPC] 1 0.0000